Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Holzer, M. T. Krusche, M. Ruffer, N. Haberstock, H. Stephan, M. Huber, T. B. Kötter, I.

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, C. C. Chen, C. J.

New-onset inflammatory arthritis after COVID-19 vaccination: A systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Pinatel, N. Plotton, C. Pozzetto, B. Gocko, X.

Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature

  • Healthcare workers
  • Influenza
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Kumari, S. Anand, R. Sambyal, B. Singh, Y. Rangappa, P. Jha, S. K.

Ocular adverse effects of COVID-19 vaccines: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Abu Serhan, H. Abdelaal, A. Abuawwad, M. T. Taha, M. J. J. Irshaidat, S. Abu Serhan, L. Abu-Ismail, L. Abu Salim, Q. F. Abdelazeem, B. Elnahry, A. G.

Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Andani, A. van Damme, P. Bunge, E. M. Salgado, F. van Hoorn, R. C. Hoet, B.

One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review

  • All age groups
  • Hepatitis A
  • Efficacy/effectiveness
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Di Spirito, F. Amato, A. Di Palo, M. P. Contaldo, M. D'Ambrosio, F. Lo Giudice, R. Amato, M.

Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Valdecantos, R. L. Palladino, R. Lo Vecchio, A. Montella, E. Triassi, M. Nardone, A.

Organisational and Structural Drivers of Childhood Immunisation in the European Region: A Systematic Review

  • Europe
  • Newborn
  • Children
  • Parents/caregivers
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Reininghaus, E. Z. Manchia, M. Dalkner, N. Bonkat, N. Squassina, A. Hodl, I. Vieta, E. Reif, A. Hajek, T. Landen, M. Correll, C. U. Scott, J. Etain, B. Rietschel, M. Bergink, V. Martinez-Cengotitabengoa, M. Kessing, L. V. Fagiolini, A. Bauer, M. Goodwin, G. Gonzalez-Pinto, A. Kupka, R. W. Schulze, T. G. Lagerberg, T. V. Yildiz, A. Henry, C. Morken, G. Ritter, P. Nieslen, R. E. Licht, R. W. Bechdolf, A. Andreassen, O. A. Fellendorf, F. T.

Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Matar, R. H. Than, C. A. Nakanishi, H. Daniel, R. S. Smayra, K. Sim, B. L. Beran, A. Danoun, O. A.

Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...